BioXcel Therapeutics' GAAP loss for 9M 2021 was $80.806 million, up 32.3% from $61.083 million in the prior year.
BioXcel Therapeutics' GAAP loss for 9M 2021 was $80.806 million, up 32.3% from $61.083 million in the prior year.
Financial results
BioXcel Therapeutics' GAAP loss for 9M 2021 was $80.806 million, up 32.3% from $61.083 million in the prior year. Source: 
ir.bioxceltherapeutics.com
ir.bioxceltherapeutics.com
English (US) 